Jagsonpal Pharmaceuticals Limited — Important, 23-10-2024: Financial Result Updates

Jagsonpal Pharmaceuticals Limited has reported its unaudited financial results for the quarter and half year ending September 30, 2024, and approved a sub-division of equity shares from Rs. 5 to Rs. 2, pending shareholder approval. This initiative aims to increase share liquidity and make investments more accessible for small investors. The company also plans to amend its Memorandum and Articles of Association accordingly. Net profits and total assets have shown growth compared to previous periods.